Amundi
NVO

Amundi’s Novo Nordisk NVO Stock Holding History

Amundi’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,938,507
Closed -$332M – 2010
2025
Q1 		$332M Buy
4,938,507
+1,627,051
+49% +$134M 0.12% 175
2024
Q4 		$284M Buy
3,311,456
+692,567
+26% +$74.9M 0.1% 200
2024
Q3 		$307M Buy
2,618,889
+280,325
+12% +$37.4M 0.11% 182
2024
Q2 		$325M Buy
2,338,564
+175,951
+8% +$23.3M 0.12% 163
2024
Q1 		$266M Buy
2,162,613
+671,375
+45% +$79.9M 0.11% 188
2023
Q4 		$159M Buy
1,491,238
+1,359,388
+1,031% +$134M 0.07% 289
2023
Q3 		$13.5M Sell
131,850
-48,878
-27% -$4.31M 0.01% 779
2023
Q2 		$14.4M Sell
180,728
-141,680
-44% -$11.6M 0.01% 768
2023
Q1 		$25.5M Sell
322,408
-311,190
-49% -$22.1M 0.01% 664
2022
Q4 		$42M Sell
633,598
-5,242
-0.8% -$307K 0.02% 539
2022
Q3 		$33.9M Sell
638,840
-56,132
-8% -$3.01M 0.02% 584
2022
Q2 		$38M Sell
694,972
-122,538
-15% -$6.8M 0.03% 499
2022
Q1 		$49.8M Buy
817,510
+2,668
+0.3% +$137K 0.03% 467
2021
Q4 		$40.6M Buy
814,842
+9,202
+1% +$499K 0.03% 521
2021
Q3 		$38.7M Sell
805,640
-273,052
-25% -$13.2M 0.03% 516
2021
Q2 		$45.2M Buy
+1,078,692
New +$41.8M 0.03% 465

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Amundi's NVO Position: Q2 2025 in Review

Amundi sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 4,938,507 shares — an estimated $332M sold.

Amundi first reported a position in NVO in Q2 2021 and held it in 16 quarters. The position peaked at $332M in Q1 2025. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Amundi reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 4,938,507 Novo Nordisk shares in Q2 2025, an estimated $332M.
  • Amundi first reported a position in Novo Nordisk in Q2 2021 and held it in 16 quarters.
  • Amundi's Novo Nordisk position peaked at $332M in Q1 2025.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.